OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
Over the last 12 months, insiders at OraSure Technologies, Inc. have bought $0 and sold $205,646 worth of OraSure Technologies, Inc. stock.
On average, over the past 5 years, insiders at OraSure Technologies, Inc. have bought $781,521 and sold $161,623 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100,000 shares for transaction amount of $492,810 was made by McGrath Kenneth J (Chief Financial Officer) on 2023‑05‑30.
2023-12-19 | Sale | Weber Kathleen Gallagher | Chief Product Officer | 24,129 0.0327% | $8.05 | $194,219 | -22.40% | |
2023-08-15 | Sale | Anthony Michele Marie | SVP Finance & CAO | 1,758 0.0024% | $6.50 | $11,427 | -5.26% | |
2023-05-30 | McGrath Kenneth J | Chief Financial Officer | 100,000 0.1373% | $4.93 | $492,810 | +22.40% | ||
2022-08-26 | LANCASTER RONNY B | 50,000 0.0689% | $4.00 | $200,000 | +28.00% | |||
2022-08-25 | Aspinall Mara G. | 6,000 0.0083% | $4.19 | $25,138 | +22.20% | |||
2022-08-17 | Gagliano Nancy J | 2,200 0.0031% | $4.39 | $9,658 | +17.91% | |||
2022-08-12 | Celano Michael | 12,000 0.0163% | $4.49 | $53,916 | +10.96% | |||
2020-12-23 | Sale | Weber Kathleen Gallagher | EVP & BU Lead - Molecular | 10,000 0.0141% | $11.76 | $117,600 | -9.40% | |
2019-05-14 | TANG STEPHEN S PHD | President and CEO | 2,000 0.0032% | $8.56 | $17,120 | -7.44% | ||
2019-05-13 | JERRETT JACK E | SVP & General Counsel | 20,000 0.0325% | $8.55 | $170,974 | -5.05% | ||
2019-05-10 | Cuca Roberto | CFO | 20,000 0.032% | $9.03 | $180,627 | -11.69% | ||
2019-04-01 | Sale | TANG STEPHEN S PHD | President and CEO | 33,334 0.0474% | $9.71 | $323,768 | -26.92% | |
2018-08-27 | Sale | Patrick Charles W | director | 16,000 0.0262% | $16.29 | $260,640 | -31.51% | |
2018-02-16 | Sale | SMITH BRIAN | EVP & BU Lead - Molecular | 20,000 0.0215% | $11.98 | $239,600 | -12.28% | |
2018-02-15 | Sale | TANG STEPHEN S PHD | director | 46,666 0.056% | $13.15 | $613,495 | -10.94% | |
2018-02-15 | Sale | SMITH BRIAN | EVP & BU Lead - Molecular | 20,000 0.0218% | $11.95 | $239,040 | -10.94% | |
2017-11-07 | Aspinall Mara G. | director | 5,000 0.0085% | $14.23 | $71,164 | +21.88% | ||
2017-10-04 | Sale | Michels Douglas A | President & CEO | 45,846 0.0763% | $23.00 | $1.05M | -24.60% | |
2017-09-29 | Sale | Michels Douglas A | President & CEO | 50,000 0.0834% | $22.55 | $1.13M | -23.29% | |
2017-08-31 | Sale | SMITH BRIAN | See Remarks | 18,224 0.0222% | $14.95 | $272,412 | -14.60% |
Weber Kathleen Gallagher | Chief Product Officer | 254700 0.3466% | $4.20 | 0 | 2 | |
Anthony Michele Marie | SVP Finance & CAO | 86188 0.1173% | $4.20 | 0 | 1 | |
GAUSLING MICHAEL J | President & CEO | 1074876 1.4627% | $4.20 | 0 | 3 | |
Michels Douglas A | President & CEO | 720135 0.98% | $4.20 | 0 | 18 | |
McGrath Kenneth J | Chief Financial Officer | 285512 0.3885% | $4.20 | 1 | 0 | +22.4% |
Zezzo II Anthony | EVP - Infectious Diseases | 145410 0.1979% | $4.20 | 0 | 2 | |
TANG STEPHEN S PHD | President and CEO | 119960 0.1632% | $4.20 | 1 | 6 | <0.0001% |
Celano Michael | 111823 0.1522% | $4.20 | 2 | 4 | <0.0001% | |
SPAIR RONALD H | COO & CFO | 109066 0.1484% | $4.20 | 1 | 18 | <0.0001% |
LANCASTER RONNY B | 104782 0.1426% | $4.20 | 5 | 5 | <0.0001% | |
WATSON DOUGLAS G | director | 98281 0.1337% | $4.20 | 1 | 3 | <0.0001% |
JERRETT JACK E | SVP & General Counsel | 91885 0.125% | $4.20 | 1 | 8 | <0.0001% |
Aspinall Mara G. | 77218 0.1051% | $4.20 | 2 | 0 | +22.04% | |
PRINGLE ROGER L | director | 76452 0.104% | $4.20 | 1 | 1 | <0.0001% |
ZACK JOSEPH E | Exec. VP - Mktg. and Sales | 64015 0.0871% | $4.20 | 0 | 2 | |
Patrick Charles W | director | 54298 0.0739% | $4.20 | 1 | 9 | <0.0001% |
KUNA MARK L | SVP & Controller | 48491 0.066% | $4.20 | 0 | 19 | |
Cuca Roberto | CFO | 47575 0.0647% | $4.20 | 1 | 0 | <0.0001% |
Lee Stephen R | Exec. VP & CSO | 45923 0.0625% | $4.20 | 0 | 9 | |
Gagliano Nancy J | 42160 0.0574% | $4.20 | 1 | 0 | +17.91% | |
SMITH BRIAN | EVP & BU Lead - Molecular | 18075 0.0246% | $4.20 | 0 | 4 |
BlackRock | $77.5M | 17.04 | 12.6M | -0.16% | -$125,712.15 | <0.01 | |
The Vanguard Group | $33.27M | 7.31 | 5.41M | +1.88% | +$612,367.80 | <0.01 | |
Dimensional Fund Advisors | $27.8M | 6.11 | 4.52M | +15.72% | +$3.78M | 0.01 | |
Camber Capital Management Lp | $26.14M | 5.75 | 4.25M | 0% | +$0 | 0.92 | |
Neuberger Berman | $24.96M | 5.49 | 4.06M | +29.73% | +$5.72M | 0.02 | |
State Street | $19.44M | 4.27 | 3.16M | +8.26% | +$1.48M | <0.01 | |
Cannell Capital LLC | $11.85M | 2.6 | 1.93M | -45.73% | -$9.98M | 2.79 | |
Renaissance Technologies | $11.67M | 2.57 | 1.9M | +14.48% | +$1.48M | 0.02 | |
Geode Capital Management | $10.13M | 2.23 | 1.65M | +3.54% | +$346,955.88 | <0.01 | |
Acadian Asset Management | $9.78M | 2.15 | 1.59M | +46.37% | +$3.1M | 0.03 | |
Morgan Stanley | $9.19M | 2.02 | 1.49M | -8.41% | -$843,361.85 | <0.01 | |
American Century Investments | $8.56M | 1.88 | 1.39M | +70.35% | +$3.53M | 0.01 | |
American Capital Management, Inc. | $8.53M | 1.88 | 1.39M | -3.04% | -$267,875.54 | 0.27 | |
Invesco | $7.17M | 1.58 | 1.17M | -21.04% | -$1.91M | <0.01 | |
Systematic Financial Management LLC | $6.79M | 1.49 | 1.1M | -2.55% | -$177,421.45 | 0.19 | |
Bridgeway Capital Management | $4.97M | 1.09 | 807,429 | +1.7% | +$82,871.24 | 0.09 | |
Charles Schwab | $4.77M | 1.05 | 775,628 | +0.1% | +$4,944.60 | <0.01 | |
Northern Trust | $4.62M | 1.02 | 750,813 | -2.77% | -$131,782.20 | <0.01 | |
PRIMECAP Management Co | $4.54M | 1 | 738,520 | -3.05% | -$142,680.00 | <0.01 | |
Wells Fargo | $4.31M | 0.95 | 700,805 | -2.92% | -$129,820.24 | <0.01 | |
BNY Mellon | $4.13M | 0.91 | 670,732 | -3.09% | -$131,646.87 | <0.01 | |
AQR Capital | $3.8M | 0.84 | 617,574 | -25.71% | -$1.31M | 0.01 | |
Panagora | $3.57M | 0.79 | 581,115 | +50.22% | +$1.19M | 0.02 | |
Goldman Sachs | $3.14M | 0.69 | 509,883 | +60.17% | +$1.18M | <0.01 | |
GlobeFlex Capital | $3.08M | 0.68 | 500,158 | -4.55% | -$146,493.01 | 0.3 | |
Allspring Global Investments | $3.03M | 0.67 | 492,477 | +135.1% | +$1.74M | 0.01 | |
Bank of America | $2.59M | 0.57 | 421,415 | +583.63% | +$2.21M | <0.0001 | |
Nuveen | $2.49M | 0.55 | 404,066 | -20.51% | -$641,217.48 | <0.01 | |
Arrowstreet Capital, Limited Partnership | $2.37M | 0.52 | 385,190 | -17.98% | -$519,139.36 | <0.01 | |
Allianz Asset Management Gmbh | $2.32M | 0.51 | 377,457 | +210.05% | +$1.57M | <0.01 | |
Los Angeles Capital Management LLC | $2.1M | 0.46 | 341,125 | +2.56% | +$52,416.46 | 0.01 | |
Hrt Financial Llc | $2.08M | 0.46 | 337,705 | New | +$2.08M | 0.01 | |
Prudential Financial | $1.96M | 0.43 | 318,645 | -27.92% | -$758,910.10 | <0.01 | |
JPMorgan Chase | $1.7M | 0.37 | 275,980 | +61.08% | +$643,579.05 | <0.0001 | |
Fisher Asset Management Llc | $1.67M | 0.37 | 270,885 | -6.17% | -$109,519.15 | <0.01 | |
Ameriprise Financial | $1.63M | 0.36 | 264,917 | -0.08% | -$1,340.70 | <0.0001 | |
Jupiter Fund Management | $1.6M | 0.35 | 259,972 | New | +$1.6M | <0.01 | |
Millennium Management LLC | $1.5M | 0.33 | 244,259 | +725.2% | +$1.32M | <0.01 | |
Trexquant Investment LP | $1.49M | 0.33 | 242,215 | +46.62% | +$473,636.02 | 0.02 | |
RhumbLine Advisers | $1.41M | 0.31 | 229,489 | +1.55% | +$21,549.35 | <0.01 | |
Martingale Asset Management L P | $1.39M | 0.31 | 225,619 | +5.38% | +$70,829.61 | 0.03 | |
Prelude Capital | $1.29M | 0.28 | 209,642 | -14.43% | -$217,340.95 | 0.09 | |
Legal & General | $1.28M | 0.28 | 208,883 | +0.74% | +$9,489.46 | <0.0001 | |
First Trust | $1.28M | 0.28 | 208,233 | +3.12% | +$38,726.52 | <0.01 | |
Exchange Traded Concepts, LLC | $1.27M | 0.28 | 207,163 | New | +$1.27M | 0.03 | |
Archon Capital Management Llc | $1.27M | 0.28 | 206,742 | -83.34% | -$6.36M | 0.03 | |
Qube Research & Technologies | $1.25M | 0.28 | 203,199 | New | +$1.25M | <0.01 | |
Brandywine Global Investment Management | $1.24M | 0.27 | 200,883 | -0.74% | -$9,243.45 | 0.01 | |
Deutsche Bank | $1.19M | 0.26 | 193,075 | -1.31% | -$15,762.45 | <0.01 | |
Empowered Funds Llc | $1.1M | 0.24 | 179,229 | +8.13% | +$82,871.22 | 0.02 |